Related Experiment Video
Updated: Aug 14, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Pathologic diagnosis of acute lymphocytic leukemia
R Lai1, C F Hirsch-Ginsberg, C Bueso-Ramos
1Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Optimal acute lymphoblastic leukemia (ALL) management requires comprehensive diagnostic techniques, including morphology, immunologic, and molecular methods. Further research at specialized centers will improve understanding of leukemogenesis and treatment strategies for refractory disease.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Acute lymphoblastic leukemia (ALL) management necessitates integrated diagnostic approaches.
- Current diagnostic tools are essential but may not fully capture disease complexity.
Purpose of the Study:
- To outline an algorithm for the diagnostic evaluation and classification of ALL.
- To emphasize the need for advanced molecular studies in specialized centers for improved patient care.
Main Methods:
- Morphology, cytochemistry, cytogenetics, immunophenotyping, and molecular techniques are utilized for diagnosis.
- DNA/cDNA microarray analysis is highlighted as a significant research tool.
Main Results:
- A diagnostic and classification algorithm for ALL is presented.
- Advanced studies at specialized centers are crucial for detailed patient investigations.
Conclusions:
- Comprehensive multi-technique evaluation is key for optimal ALL patient management.
- Further research into cellular markers, bilineage leukemias, and leukemogenesis mechanisms will enhance treatment and prevent refractoriness.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019